Risk Factors for Recurrence of Radically Resected Mucinous Colorectal Adenocarcinoma

References

• Siegel RL, Miller KD, Goding SA, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.2160132133645
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.2166033538338
   PubMed Web of Science ®Google Scholar
• Hamilton SRBFBP. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon: IARC Press; 2010.
   Google Scholar
• Li C, Zheng H, Jia H, et al. Prognosis of three histological subtypes of colorectal adenocarcinoma: a retrospective analysis of 8005 Chinese patients. Cancer Med. 2019;8(7):3411–3419. doi:10.1002/cam4.223431074597
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Taniguchi H, Fujita S, et al. Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma. Histopathology. 2012;61(2):162–169. doi:10.1111/j.1365-2559.2012.04235.x22448644
   PubMed Web of Science ®Google Scholar
• Park JS, Huh JW, Park YA, et al. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer. Medicine (Baltimore). 2015;94(15):e658. doi:10.1097/MD.000000000000065825881840
   PubMed Web of Science ®Google Scholar
• Hyngstrom JR, Hu CY, Xing Y, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012;19(9):2814–2821. doi:10.1245/s10434-012-2321-722476818
   PubMed Web of Science ®Google Scholar
• Khan M, Loree JM, Advani SM, et al. Prognostic implications of mucinous differentiation in metastatic colorectal carcinoma can be explained by distinct molecular and clinicopathologic characteristics. Clin Colorectal Cancer. 2018;17(4):e699–e709. doi:10.1016/j.clcc.2018.07.00530205948
   PubMed Web of Science ®Google Scholar
• Maisano R, Azzarello D, Maisano M, et al. Mucinous histology of colon cancer predicts poor outcomes with FOLFOX regimen in metastatic colon cancer. J Chemother. 2012;24(4):212–216. doi:10.1179/1973947812Y.000000001323040685
   PubMed Web of Science ®Google Scholar
• Mekenkamp LJ, Heesterbeek KJ, Koopman M, et al. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer. 2012;48(4):501–509. doi:10.1016/j.ejca.2011.12.00422226571
   PubMed Web of Science ®Google Scholar
• Kim SH, Shin SJ, Lee KY, et al. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study. Ann Surg Oncol. 2013;20(11):3407–3413. doi:10.1245/s10434-013-3169-123943026
   PubMed Web of Science ®Google Scholar
• Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25(1):1–42.31203527
   PubMed Web of Science ®Google Scholar
• China NHCO. [Chinese protocol of diagnosis and treatment of colorectal cancer (2020 edition)]. Zhonghua Wai Ke Za Zhi. 2020;58(8):561–585. doi:10.3760/cma.j.cn112139-20200518-0039032727186
   PubMedGoogle Scholar
• Hugen N, Brown G, Glynne-Jones R, de Wilt JH, Nagtegaal ID. Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol. 2016;13(6):361–369. doi:10.1038/nrclinonc.2015.14026323388
   PubMed Web of Science ®Google Scholar
• Edge SRBC SB. AJCC Cancer Staging Manual. 7th ed. New York: Springer-Verlag; 2010.
   Google Scholar
• Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002.
   Google Scholar
• Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis. 2009;11(4):354–364, 364–365. doi:10.1111/j.1463-1318.2008.01735.x
   Web of Science ®Google Scholar
• Heald RJ. The ‘Holy Plane’ of rectal surgery. J R Soc Med. 1988;81(9):503–508. doi:10.1177/0141076888081009043184105
   PubMed Web of Science ®Google Scholar
• Huang Q, Zou MH, Jiang Y, et al. Outcomes of laparoscopic surgery for mucinous colorectal adenocarcinoma. J Laparoendosc Adv Surg Tech A. 2020. doi:10.1089/lap.2020.0588
   Web of Science ®Google Scholar
• Parham D. Colloid Carcinoma. Ann Surg. 1923;77(1):90–105.17864773
   PubMedGoogle Scholar
• Li ZP, Liu XY, Kao XM, et al. Clinicopathological characteristics and prognosis of colorectal mucinous adenocarcinoma and nonmucinous adenocarcinoma: a surveillance, epidemiology, and end results (SEER) population-based study. Ann Transl Med. 2020;8(5):205. doi:10.21037/atm.2020.01.5232309352
   PubMed Web of Science ®Google Scholar
• Yu F, Huang L, Shen F, Wu S, Chen J. Prognostic implications of mucinous histology in stage III colon cancer with the receipt of adjuvant chemotherapy. J Gastrointest Oncol. 2020;11(5):858–869. doi:10.21037/jgo-20-16033209482
   PubMed Web of Science ®Google Scholar
• Andrici J, Farzin M, Sioson L, et al. Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer. Mod Pathol. 2016;29(3):266–274. doi:10.1038/modpathol.2015.15926769140
   PubMed Web of Science ®Google Scholar
• Williams DS, Mouradov D, Newman MR, et al. Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation. Mod Pathol. 2020;33(7):1420–1432. doi:10.1038/s41379-020-0496-132047231
   PubMed Web of Science ®Google Scholar
• Catalano V, Loupakis F, Graziano F, et al. Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol. 2012;23(1):135–141. doi:10.1093/annonc/mdr06221531784
   PubMed Web of Science ®Google Scholar
• Fields AC, Lu P, Goldberg J, Irani J, Bleday R, Melnitchouk N. The role of adjuvant chemotherapy in stage II and III mucinous colon cancer. J Surg Oncol. 2019;120(7):1190–1200. doi:10.1002/jso.2570531536150
   PubMed Web of Science ®Google Scholar
• Hugen N, Verhoeven RH, Radema SA, et al. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma. Ann Oncol. 2013;24(11):2819–2824. doi:10.1093/annonc/mdt37824057984
   PubMed Web of Science ®Google Scholar
• Wang L, Hirano Y, Heng G, et al. Mucinous adenocarcinoma as a high-risk factor in stage ii colorectal cancer: a propensity score-matched study from Japan. Anticancer Res. 2020;40(3):1651–1659. doi:10.21873/anticanres.1411532132070
   PubMed Web of Science ®Google Scholar
• Ott C, Gerken M, Hirsch D, et al. Advanced mucinous colorectal cancer: epidemiology, prognosis and efficacy of chemotherapeutic treatment. Digestion. 2018;98(3):143–152. doi:10.1159/00048771029870979
   PubMed Web of Science ®Google Scholar
• Hugen N, van Beek JJ, de Wilt JH, Nagtegaal ID. Insight into mucinous colorectal carcinoma: clues from etiology. Ann Surg Oncol. 2014;21(9):2963–2970. doi:10.1245/s10434-014-3706-624728741
   PubMed Web of Science ®Google Scholar
• Emile SH, Magdy A, Elnahas W, Hamdy O, Abdelnaby M, Khafagy W. Predictors for local recurrence and distant metastasis of mucinous colorectal adenocarcinoma. Surgery. 2018;164(1):56–65. doi:10.1016/j.surg.2017.11.028
   Web of Science ®Google Scholar
• Aoyama T, Oba K, Honda M, et al. Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients’ data from three large Phase III randomized trials. Cancer Med. 2017;6(7):1573–1580. doi:10.1002/cam4.112628639738
   PubMed Web of Science ®Google Scholar
• Catalano V, Loupakis F, Graziano F, et al. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer. 2009;100(6):881–887. doi:10.1038/sj.bjc.660495519259089
   PubMed Web of Science ®Google Scholar
• Bagante F, Spolverato G, Beal E, et al. Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer. J Surg Oncol. 2018;117(7):1355–1363. doi:10.1002/jso.2504429574929
   PubMed Web of Science ®Google Scholar
• Gonzalez RS, Cates J, Washington K. Associations among histological characteristics and patient outcomes in colorectal carcinoma with a mucinous component. Histopathology. 2019;74(3):406–414. doi:10.1111/his.1374830160323
   PubMed Web of Science ®Google Scholar
• Hugen N, van de Velde CJ, Bosch SL, et al. Modern treatment of rectal cancer closes the gap between common adenocarcinoma and mucinous carcinoma. Ann Surg Oncol. 2015;22(8):2669–2676. doi:10.1245/s10434-014-4339-525564178
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.29395269
   PubMed Web of Science ®Google Scholar
• Van Blarigan EL, Fuchs CS, Niedzwiecki D, et al. Association of survival with adherence to the american cancer society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis: the CALGB 89803/Alliance Trial. JAMA Oncol. 2018;4(6):783–790. doi:10.1001/jamaoncol.2018.012629710284
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels J, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-031631858
   PubMed Web of Science ®Google Scholar